Advertisement


Tara O. Henderson, MD, MPH, on Cancer Survivors With Complex Medical Needs

2016 Cancer Survivorship Symposium

Advertisement

Tara O. Henderson, MD, MPH, of the University of Chicago, summarizes a session on the multidisciplinary approaches to survivors with medical needs beyond cancer treatment.



Related Videos

Survivorship

Kerri M. Winters-Stone, PhD, on Peripheral Neuropathy: High Prevalence Among Female Survivors

Kerri M. Winters-Stone, PhD, of Oregon Health and Science University, discusses the results of her study, which showed that, years after treatment, nearly half of women cancer survivors still have symptoms of chemotherapy-induced peripheral neuropathy. The findings may inform rehabilitative programs to prevent falls and injuries (Abstract 130).

Survivorship

Rachel Lynn Yung, MD, on Weight-Loss Intervention in Obese Survivors

Rachel Lynn Yung, MD, of the Dana-Farber Cancer Institute, discusses her study of a clinic-based intervention for overweight cancer survivors, which resulted in weight loss and improvements in fitness and physical functioning (Abstract 167).

Survivorship

Lewis E. Foxhall, MD, on Communication and Coordination of Survivorship Care

Lewis E. Foxhall, MD, of The University of Texas MD Anderson Cancer Center, summarizes this session in which presenters covered a range of issues, including the medical home, tools to facilitate communication with cancer survivors, EMRs, reimbursement, and coordinating care with primary care providers (Abstract 76 was presented in this session).

Survivorship

Smita Bhatia, MD, MPH, on the Science of Survivorship

Smita Bhatia, MD, MPH, of the University of Alabama at Birmingham, discusses long-term and late effects experienced by cancer survivors.

Survivorship
Thyroid Cancer

Dana Barnea, MD, on Screening Survivors for Thyroid Cancer

Dana Barnea, MD, of Memorial Sloan Kettering Cancer Center, discusses data that suggest annual palpation of the thyroid is an adequate and safe means of screening childhood and young adult cancer survivors, a population at high risk for this type of cancer (Abstract 254).

Advertisement

Advertisement




Advertisement